Jeong-woo Oh

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma.

Patient-derived organoids predict personalized drug response and reveal alternative therapeutic options in glioblastoma.

Journal: Cell reports. Medicine
Published: February 22, 2025

Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.

Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.

Journal: Genome medicine
Published: September 21, 2022

High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma.

High-Content Analysis-Based Sensitivity Prediction and Novel Therapeutics Screening for c-Met-Addicted Glioblastoma.

Journal: Cancers
Published: December 30, 2020

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target.

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target.

Journal: Experimental & molecular medicine
Published: November 05, 2020

DeepHCS++: Bright-field to fluorescence microscopy image conversion using multi-task learning with adversarial losses for label-free high-content screening.

DeepHCS++: Bright-field to fluorescence microscopy image conversion using multi-task learning with adversarial losses for label-free high-content screening.

Journal: Medical image analysis
Published: February 13, 2020

The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling.

The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling.

Journal: Cancers
Published: October 17, 2019

Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models.

Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models.

Journal: Cancers
Published: May 11, 2019

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers.

Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers.

Journal: Genome biology
Published: April 09, 2019

Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.

Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.

Journal: Experimental & molecular medicine
Published: March 02, 2019

Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells.

Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells.

Journal: Cell death & disease
Published: January 29, 2018

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.

Journal: Nature genetics
Published: June 14, 2017
Showing 1-11 of 11

Last Updated: 09/26/2026